Skip to main content
NIH funding notice RFA-NS-21-015

HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)

Closed on April 22, 2022.

Posted
March 11, 2021
Close date
April 22, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$6,789,851
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. MARINE BIOLOGICAL LABORATORY1

Most frequent study sections

  1. Special Emphasis Panel (ZNS1 SRB-C (11))1
1 award under RFA-NS-21-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2021Site-directed RNA editing of Nav1.7 as a novel analgesic1U19NS126038-01Dib-Hajj, Sulayman DDussor, Gregory OEisenberg, EliRosenthal, Joshua J.c.MARINE BIOLOGICAL LABORATORY, MAFirst-year cost $6,789,851Study section ZNS1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.